Spectrum Pharmaceuticals, Inc. Shares Approach 52-Week Low - Market Mover
The shares closed 1.2% above its 52-week low of $1.67, with trading volume higher than its 30 day average
Nov 27, 2021 by Kwhen Finance Editors
Spectrum Pharmaceuticals, Inc. (SPPI) shares closed today at 1.2% above its 52 week low of $1.67, giving the company a market cap of $277M. The stock is currently down 50.4% year-to-date, down 62.9% over the past 12 months, and down 61.0% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%.
Trading Activity
- Trading volume this week was 564.9% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Spectrum Pharmaceuticals, Inc. | -4.0 | -50.4 | -62.9 | -66.8 | 4.2 |
| Dow Jones Industrial Average | -2.5 | 15.9 | 18.8 | -4.0 | 20.9 |
| S&P 500 Index | -2.2 | 24.0 | 28.3 | -2.3 | 30.6 |
| Health Care | -0.5 | 16.2 | 22.5 | -3.2 | 22.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -2318.9%
- The company's stock price performance over the past 12 months lags the peer average by -276.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Spectrum Pharmaceuticals, Inc. | SPPI | 0 | -50.4 | -62.9 | -66.8 | 4.2 |
| Peer Avg | N/A | 2.9 | 2.3 | 35.7 | -21.8 | 53.2 |
| Johnson & Johnson | JNJ | 23.4 | 3.7 | 13.6 | -9.7 | 15.1 |
| Pfizer Inc. | PFE | 15.8 | 52.4 | 53.6 | -1.7 | 66.4 |
| Abbott Laboratories | ABT | 30.5 | 16.0 | 19.4 | -2.9 | 23.2 |
| Novartis AG - ADR | NVS | 34.6 | -9.8 | -4.5 | -14.7 | 0.2 |
| Bristol-Myers Squibb Co. | BMY | -23.2 | -6.7 | -7.2 | -18.6 | 0.9 |
| Glaxosmithkline plc - ADR | GSK | 15.9 | 17.9 | 16.5 | -4.3 | 27.8 |
| Biogen Inc | BIIB | 23.8 | 2.2 | 3.5 | -46.5 | 5.2 |
| Seagen Inc | SGEN | -93.1 | -3.2 | 2.4 | -12.8 | 32.6 |
| Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 12.9 | -12.0 | -12.9 | -35.7 | 3.8 |
| Curis Inc | CRIS | -11.9 | -37.7 | 272.3 | -71.4 | 356.9 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: